Page 33 - Service Testing News Today

Lilly reached a deal to buy Versanis Bio, a privately held biotech which is testing a monoclonal antibody drug called bimagrumab as a new treatment for obesity.

By Denny Jacob Moleculin Biotech shares rose 17% to 72 cents after it said published data from a Phase 1 clinical trial of annamycin continued to not show...

By Dean Seal Salarius Pharmaceuticals said regulators have cleared an investigational drug application to start a clinical trial for its lymphoma treatment...

By Dean Seal Shares of Incannex Healthcare are trading higher after the company said it has received approval from the Bellberry Human Research Ethics...

By Chris Wack Allarity Therapeutics shares were up 87% to $11.78 Wednesday after the company said it saw positive initial results from its European Phase 2...

By Paul Ziobro AbbVie and Genmab said Tuesday that a clinical trial for a bispecific antibody to treat a form of non-Hodgkin's lymphoma would need further...

By Ben Glickman Shares of Cognition Therapeutics surged Wednesday morning after the company said a Phase 2 study of its treatment for Alzheimer's disease...

An ongoing medical conference is showing that patients will have a choice of ways to take the new generation of weight-loss drugs called incretins.

By Josh Beckerman Adicet Bio shares fell 54% to $2.15 on Tuesday after the company reported data from an ongoing Phase 1 study of ADI-001 for the potential...

The Food and Drug Administration rejected its application for approval of a new, higher-dose version of eye disease treatment Eylea.